Cargando…

“One pill, once daily”: what clinicians need to know about Atripla™

As the number of persons chronically prescribed antiretrovirals has grown and the realization that antiretrovirals are required to be continued for life, pharmaceutical manufacturers have developed new classes of agents, improved the pharmacokinetics of marketed products through dosing reformulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Clay, Patrick G, Taylor, Tracey AH, Glaros, Alan G, McRae, MaryPeace, Williams, Charlott, McCandless, Don, Oelklaus, Maurice
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504066/
https://www.ncbi.nlm.nih.gov/pubmed/18728842

Ejemplares similares